SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1801MGI Pharma downgraded to "sell" Monday, November 12, 2007 9:25:52 AM Icebrg-11/12/2007
1800MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application sim1-10/29/2007
1799>>Aquavan(R) Phase 3 Bronchoscopy Data Presented At CHEST 2007 Monday Octotuck-10/22/2007
1798MGI Pharma initiated with "buy" Wednesday, October 17, 2007 10:54:50 Icebrg-10/22/2007
1797MGI Pharma "outperform," target price raised Friday, October 19, 2007Icebrg-10/22/2007
1796MGI Pharma "strong sell" Thursday, October 18, 2007 7:25:31 AM ET MatIcebrg-10/22/2007
1795MGI Pharma downgraded to "hold" Thursday, October 18, 2007 10:15:23 AIcebrg-10/22/2007
1794MGI Pharma "neutral," target price raised Thursday, October 18, 2007 Icebrg-10/22/2007
1793MGI Pharma "neutral," target price reduced Thursday, October 18, 2007Icebrg-10/22/2007
1792Moulder and/or the MOGN staff have been extremely successful in bringing in new Icebrg-10/22/2007
1791Act fast if you want to hear the CC. Here's the PR. Aside from the somewhatuck-10/22/2007
1790MGI Pharma "buy," target price raised - update Friday, October 19, 20Icebrg-10/21/2007
1789Aloxi(R) Phase 3 Data for Post Operative Nausea and Vomiting (PONV) Presented atsim1-10/15/2007
1788JPMorgan on MOGN: Analyst Says MGI Pharma Will Rise As Aloxi and Dacogen Salessim1-10/10/2007
1787Merrill on MOGN: MGI Pharma (MOGN, US$29.75, C-1-9) Raising PO to $35 on greatetom pope-10/8/2007
1786For Biotechs, Waiting Until All Data Are In Has Its Rewards online.wsj.com NEWElmer Flugum-9/27/2007
1785MGI PHARMA Announces Submission of Aquavan(R) New Drug Application Thursday SeptIcebrg-9/27/2007
1784Decitabine and its role in the treatment of hematopoietic malignancies. Leuk LyIcebrg-8/31/2007
1783MGI Paying $45M Up Front For Thrombocytopenia Drug By Jennifer Boggs Staff WriteIcebrg-8/30/2007
1782<<Why would propofol require an anesthesiologist and aquavan wouldn't?Ward Knutson-8/29/2007
1781Yes, indeed. Erik posted on why there might be economic incentive to use propoftuck-8/29/2007
1780Why would propofol require an anesthesiologist and aquavan wouldn't? Isn'rkrw-8/29/2007
1779Interesting thread on the ymb started by a poster claiming to be an anesthesiolotuck-8/29/2007
1778T'is relevant, yes, thanks, but not a full text freebie. Cheers, Tucktuck-8/29/2007
1777Is this abstract relevant? It appeared to me that YM477 is the same as and was rsim1-8/28/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News